Mitazalimab

MedChem Express

Mitazalimab

10

Research Use Only

99.23

Mitazalimab (ADC-1013; JNJ-64457107) is FcgammaR-dependent CD40 agonist with tumor-directed activity. Mitazalimab activates antigen-presenting cells, e.g. dendritic cells (DC), to initiate tumor-reactive T cells. Therefore, Mitazalimab induces tumor-specific T cells to infiltrate and kill tumors. Mitazalimab remodels the tumor-infiltrating myeloid microenvironment[1][2].

-80°C

12352203